{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:46:51Z","timestamp":1793234811089,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.prostaglandins.2017.08.008","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T01:31:02Z","timestamp":1502933462000},"page":"75-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["BML-111 equilibrated ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis to protect hepatic fibrosis in rats"],"prefix":"10.1016","volume":"131","author":[{"given":"Quandong","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.plefa.2005.05.002","article-title":"Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution","volume":"73","author":"Serhan","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.bjp.0705220","article-title":"A novel rat lipoxin A4 receptor that is conserved in structure and function","volume":"139","author":"Chiang","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0015","doi-asserted-by":"crossref","first-page":"C870","DOI":"10.1152\/ajpcell.1999.277.5.C870","article-title":"Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A (4)","volume":"277","author":"Titos","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0020","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1189\/jlb.1204747","article-title":"Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells","volume":"78","author":"Titos","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"17","key":"10.1016\/j.prostaglandins.2017.08.008_bib0025","first-page":"7","article-title":"BML-111 Protected LPS\/D-GalN-Induced Acute Liver Injury in Rats","volume":"13","author":"Yan","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0030","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1872-034X.2007.00154.x","article-title":"Protective effects of BML-111, a lipoxin A(4) receptor agonist, on carbon tetrachloride-induced liver injury in mice","volume":"37","author":"Zhang","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0035","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s10753-013-9643-x","article-title":"BML-11, a lipoxin receptor agonist, protected carbon tetrachloride-induced hepatic fibrosis in rats","volume":"36","author":"Zhou","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2011.05.020","article-title":"Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment","volume":"309","author":"Hao","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0045","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1158\/1535-7163.MCT-10-0173","article-title":"Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis","volume":"9","author":"Chen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0050","doi-asserted-by":"crossref","first-page":"9203716","DOI":"10.1155\/2016\/9203716","article-title":"Maresin 1, a proresolving lipid mediator, mitigates carbon tetrachloride-induced liver injury in mice","volume":"2016","author":"Li","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.08.008_bib0055","doi-asserted-by":"crossref","first-page":"L1053","DOI":"10.1152\/ajplung.00368.2015","article-title":"Lipoxin A4 prevents tight junction disruption and delays the colonization of cystic fibrosis bronchial epithelial cells by Pseudomonas aeruginosa","volume":"310","author":"Higgins","year":"2016","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0060","doi-asserted-by":"crossref","first-page":"781087","DOI":"10.1155\/2015\/781087","article-title":"Physiological impact of abnormal lipoxin A4 production on cystic fibrosis airway epithelium and therapeutic potential","volume":"2015","author":"Higgins","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.008_bib0065","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1681\/ASN.2012060550","article-title":"Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGF\u03b2R1","volume":"24","author":"Brennan","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"21","key":"10.1016\/j.prostaglandins.2017.08.008_bib0070","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.3748\/wjg.15.2579","article-title":"Renin-angiotensin system in the pathogenesis of liver fibrosis","volume":"15","author":"Pereira","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.008_bib0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.rvsc.2013.01.028","article-title":"Up-regulation of components of the renin-angiotensin system in liver fibrosis in the rat induced by CCL4","volume":"95","author":"Zhang","year":"2013","journal-title":"Res. Vet. Sci."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.08.008_bib0080","first-page":"717","article-title":"Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosis","volume":"23","author":"Huang","year":"2009","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.008_bib0085","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.23104","article-title":"Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice","volume":"50","author":"Osterreicher","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.08.008_bib0090","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3892\/ijmm_00000407","article-title":"Down-regulation of angiotensin II by shRNA reduces collagen synthesis in hepatic stellate cells","volume":"25","author":"Yu","year":"2010","journal-title":"Int. J. Mol. Med."},{"issue":"1-2","key":"10.1016\/j.prostaglandins.2017.08.008_bib0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11010-010-0542-2","article-title":"Inhibition of ATIR by shRNA prevents collagen synthesis in hepatic stellate cells","volume":"344","author":"Dong","year":"2010","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.08.008_bib0100","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/hep.21638","article-title":"Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis","volume":"45","author":"Hirose","year":"2007","journal-title":"Hepatology"},{"issue":"26","key":"10.1016\/j.prostaglandins.2017.08.008_bib0105","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.2174\/092986707782360169","article-title":"Renin-angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases","volume":"14","author":"Yoshiji","year":"2007","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.08.008_bib0110","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1113\/expphysiol.2008.042002","article-title":"Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis","volume":"93","author":"Santos","year":"2008","journal-title":"Exp. Physiol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.008_bib0115","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-12-0341","article-title":"Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system","volume":"216","author":"Santos","year":"2013","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.08.008_bib0120","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1165\/rcmb.2012-0274OC","article-title":"Lipoxin A(4) activates alveolar epithelial sodium channel, Na,K-ATPase, and increases alveolar fluid clearance","volume":"48","author":"Wang","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0125","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1021\/bi00076a002","article-title":"Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products","volume":"32","author":"Serhan","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jss.2015.09.005","article-title":"BML- 111 attenuates acute lung injury in endotoxemic mice","volume":"200","author":"Tang","year":"2016","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00011-007-7141-z","article-title":"BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis","volume":"57","author":"Zhang","year":"2008","journal-title":"Inflamm. Res."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.008_bib0140","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10753-015-0286-y","article-title":"BML-111 attenuates renal Ischemia\/Reperfusion injury via peroxisome proliferator-Activated receptor-\u03b1-Regulated heme oxygenase-1","volume":"39","author":"Wu","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0145","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.3892\/mmr.2015.3746","article-title":"Effect of BML-111 on the intestinal mucosal barrier in sepsis and its mechanism of action","volume":"12","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0150","first-page":"17824","article-title":"Wnt5a\/FZD5\/CaMKII signaling pathway mediates the effect of BML-111 on inflammatory reactions in sepsis","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0155","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/jnc.12607","article-title":"Neurovascular protection by post-ischemic intravenous injections of the lipoxin A4 receptor agonist, BML-111, in a rat model of ischemic stroke","volume":"129","author":"Hawkins","year":"2014","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.08.008_bib0160","first-page":"1471","article-title":"Research of RAAS: progress and perspective","volume":"70","author":"Akazawa","year":"2012","journal-title":"Nihon Rinsho."},{"issue":"9-10","key":"10.1016\/j.prostaglandins.2017.08.008_bib0165","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1089\/ars.2005.7.1346","article-title":"Liver fibrogenesis: a new role for the renin-angiotensin system","volume":"7","author":"Bataller","year":"2005","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.008_bib0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.hepres.2005.01.017","article-title":"Expression of angiotensin II type 1 receptor in human cirrhotic livers: its relation to fibrosis and portal hypertension","volume":"32","author":"Ikura","year":"2005","journal-title":"Hepatology Research"},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.008_bib0175","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cld.2008.07.013","article-title":"Cytokines and renin-angiotensin system signaling in hepatic fibrosis","volume":"12","author":"Moreno","year":"2008","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.008_bib0180","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1074\/jbc.M109.076216","article-title":"CD38-mediated Ca2+ signaling contributes to angiotensin II-induced activation of hepatic stellate cells: attenuation of hepatic fibrosis by CD38 ablation","volume":"285","author":"Kim","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.prostaglandins.2017.08.008_bib0185","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1042\/CBI20090074","article-title":"Angiotensin II increases mRNA levels of all TGF-beta isoforms in quiescent and activated rat hepatic stellate cells","volume":"34","author":"Moreno-Alvarez","year":"2010","journal-title":"Cell Biol. Int."},{"issue":"10","key":"10.1016\/j.prostaglandins.2017.08.008_bib0190","doi-asserted-by":"crossref","first-page":"e76289","DOI":"10.1371\/journal.pone.0076289","article-title":"Angiotensin II facilitates fibrogenic effect of TGF-\u03b21 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"SI","key":"10.1016\/j.prostaglandins.2017.08.008_bib0195","first-page":"A298","article-title":"Angiotensin-converting enzyme 2 is a negative regulator of chronic liver injury","volume":"46","author":"Oesterreicher","year":"2007","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.08.008_bib0200","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20080647","article-title":"Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat","volume":"117","author":"Lubel","year":"2009","journal-title":"Clin. Sci. (Lond)"},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.008_bib0205","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.23104","article-title":"Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice","volume":"50","author":"Osterreicher","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.008_bib0210","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.008_bib0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/ars.2013.5818","article-title":"The angiotensin-converting enzyme 2\/angiotensin (1-7)\/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA\/Rho kinase pathway","volume":"22","author":"Meng","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.008_bib0220","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1042\/CS20130585","article-title":"The Ang-(1-7)\/Mas-1 axis attenuates the expression and signalling of TGF-\u03b21 induced by AngII in mouse skeletal muscle","volume":"127","author":"Morales","year":"2014","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.008_bib0225","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1165\/rcmb.2012-0451OC","article-title":"Angiotensin-converting enzyme 2\/angiotensin-(1-7)\/Mas axis protects against lung fibrosis by inhibiting the MAPK\/NF-\u03baB pathway","volume":"50","author":"Meng","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.008_bib0230","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver-linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prostaglandins.2017.08.008_bib0235","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.008_bib0240","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/labinvest.2015.100","article-title":"ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling","volume":"96","author":"Andersson-Sj\u00f6land","year":"2016","journal-title":"Lab. Invest."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.08.008_bib0245","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s10753-013-9683-2","article-title":"Roles of lipoxin A4 in preventing paracetamol-induced acute hepatic injury in a rabbit model","volume":"36","author":"Xia","year":"2013","journal-title":"Inflammation"},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.08.008_bib0250","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1872-034X.2009.00520.x","article-title":"Lipoxin A(4) inhibited hepatocyte growth factor-induced invasion of human hepatoma cells","volume":"39","author":"Zhou","year":"2009","journal-title":"Hepatol Res."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.008_bib0255","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1681\/ASN.2012060550","article-title":"Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGF\u03b2R1","volume":"24","author":"Brennan","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.08.008_bib0260","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.4049\/jimmunol.0802259","article-title":"ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis","volume":"182","author":"Martins","year":"2009","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.prostaglandins.2017.08.008_bib0265","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00011-007-7012-7","article-title":"Effects of lipoxin A(4) on lipopolysaccharide induced proliferation and reactive oxygen species production in RAW264. 7 macrophages through modulation of G-CSF secretion","volume":"56","author":"Zhou","year":"2007","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.008_bib0270","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1160\/TH06-06-0315","article-title":"Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism","volume":"97","author":"Nascimento-Silva","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.008_bib0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0167-4838(99)00081-3","article-title":"Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects","volume":"1432","author":"Dalpiaz","year":"1999","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:09:08Z","timestamp":1750806548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882317300278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":55,"alternative-id":["S1098882317300278"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.08.008","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BML-111 equilibrated ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis to protect hepatic fibrosis in rats","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}